|4May 30, 7:29 AM ET

Fishel Robert Scott 4

4 · Opko Health, Inc. · Filed May 30, 2018

Insider Transaction Report

Form 4
Period: 2018-05-29
Transactions
  • Purchase

    Common Stock

    2018-05-29$3.73/sh+2,500$9,3334,058,228 total(indirect: See Footnote)
Footnotes (1)
  • [F1]These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION